IPNA Journal Club - IPNA Online - International Pediatric Nephrology Association (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-5B758VC'); window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-2J0EX6V8BQ');

GREAT CARE FOR LITTLE KIDNEYS. EVERYWHERE.

IPNA Online – International Pediatric Nephrology Association
  • IPNA
  • IPNA foundation

IPNA Journal Club

The official Twitter journal club of the International Pediatric Nephrology Association

HERO@2x

Introduction

IPNAJC is a pediatric nephrology journal club that uses the Zoom platform to discuss the latest updates, journal articles, and guidelines that embrace the driving force for kidney care in children.

It was formerly a Twitter journal club under the hashtag #IPNAJC. Currently, to enhance better interaction with participants, we are now hosting the discussion sessions on Zoom. The first round of the Twitter-based journal club was started in July 2022 to cover three time zones (USA Eastern Time, Central European Summer Time and Indian Standard Time) to allow global participation.

For the journal club discussion, we chose articles/ guidelines to engage the nephrology community. The author(s) or subject expert(s) are present to facilitate interactive and in-depth discussions.

Please follow IPNA Journal Club on Twitter under @ipnajc for the latest news. Please share this news to promote further pediatric nephrology education brought to you by IPNA. Subscribe to the IPNA newsletter for more updates.

introduction_image@2x

October 23, 2024 ( 9am ET/ 3pm CEST/ 6:30pm IST)

Journal club (ZOOM):
Topic:

Efficiency of Rituximab and risk factors for poor prognosis in patients with childhood SRNS- a multi-centre study.

Dear All,

On October 23, the IPNA Communication Committee invites you to join the IPNA journal club to discuss the following article:

Efficiency of Rituximab and risk factors for poor prognosis in patients with childhood SRNS- a multi-centre study.
Link to the article: https: //link.springer.com/article/10.1007/s00467-024-06422-5

Date: 23rd October, 2024
Time: 3pm CEST
Format: Zoom discussion

FREE Registration HERE

SUMMARY

July 31, 2024 ( 7am ET/ 1pm CEST/ 4:30pm IST)

Journal club (ZOOM):
Topic:

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease

Dear All,

On July 31, the IPNA Communication Committee invites you to join the IPNA journal club to discuss the following article:

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
Link to the article: https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf

We intend to cover the pediatric perspective of the changes which will focus on CKD-MBD, and anemia care.

Date: 31st July, 2024
Time: 1pm CEST
Format: Zoom discussion

FREE Registration HERE

SUMMMARY

 

 

April 24, 2024 ( 11am ET/ 5pm CET/ 9pm IST)

Journal club (ZOOM):
Topics:

1) Yield of diagnostic testing in evaluating etiology and end organ effects of pediatric hypertension.

2) Complement gene mutations in children with C3 glomerulopathy: do they affect the response to mycophenolate

Dear All,

The IPNA journal club is now adopting a new format: Zoom-based discussions of selected articles, which are more interactive and allow the audience to directly interact with the authors.

 

On April 24, the IPNA Communication Committee invites you to join the journal club to discuss the following two articles:

1) Yield of diagnostic testing in evaluating etiology and end organ effects of pediatric hypertension.

Link to the article: https://link.springer.com/article/10.1007/s00467-023-06101-x

Summary

2) Complement gene mutations in children with C3 glomerulopathy: do they affect the response to mycophenolate mofetil?

Link to the article: https://pubmed.ncbi.nlm.nih.gov/38041748/

Summary

We have the authors of the article to be in there for discussion.

January 24 & 25, 2023

Journal club 7: Effects of Bardoxolone Methyl in Alport Syndrome

Hello, #IPNAJC enthusiasts,

 

We had our 7th #IPNAJC in collaboration with #NephJC on Effects of Bardoxolone Methyl in Alport Syndrome” on Jan 24 and 25, 2023

PMID: 36411058 Link: https://journals.lww.com/cjasn/Fulltext/2022/12000/Effects_of_Bardoxolone_Methyl_in_Alport_Syndrome.9.aspx 

 

The summary was written by Drs. Priti Meena and Jamie Willows.


Infographic was created for this study by Md. Abdul Qader.

 

Please find the 10-tweet summary HERE, and PDF attached.

 

 

We look forward to seeing you next time at the IPNAJC in April 2023!

 

  1. Sudha Mannemuddhu, MD

@drM_Sudha

On behalf of the IPNA Social Media Working Group

October 5 & 6, 2022

Journal club 6: Association Between Dialysis Facility Ownership & Access to the Waiting List & Transplant in Pediatric Patients With ESKD in the US

Hello #IPNAJC enthusiasts,

We will be having the 6th #IPNAJC chat on “Association Between Dialysis Facility Ownership & Access to the Waiting List & Transplant in Pediatric Patients With ESKD in the US” on October 5 and 6, 2022.

JAMA. 2022;328(5):451-459.           doi:10.1001/jama.2022.11231

PMID: 35916847                                    PMCID: PMC934654

The summary was written by Madiha Aziz and Suprita Kalra

Infographics (EN), Infographics (ES) for this study were created by Dr. Madiha Aziz and    Dr. Franklin Loachamin.

*The summary of the IPNAJC discussion by Abdul Qadar

We look forward to seeing you at the IPNAJC!

 

IPNA Social media Sub committee

How do I participate in IPNAJC?

New to journal club? Don’t worry we have your back.

See this simple guide adapted from NephJC

How to participate in IPNAJC

IPNAJC code of conduct

This code of conduct was adapted from NephJC to guide us toward pleasant discussions during our interactions in IPNAJC chat. We believe that this will make us an effective teaching environment filled with fun, mutual respect and collaboration.

code of conduct@2x

Journal Club

International cohort of 382 children with lupus nephritis- presentation, treatment and outcome at 24 months 
October 25, 2023
Longterm efficacy & safety of Rituximab versus Tacrolimus in children with Steroid dependent nephrotic syndrome
July 26, 2023
Solitary Functioning Kidney and Kidney Injury-SOFIA study group
April 19, 2023
Association Between Dialysis Facility Ownership and Access to the Waiting list and Transplant in Pediatric Patients With End-stage Kidney Disease in the US
October 5, 2022
Ambulatory Blood Pressure Monitoring in Children and Adolescents: 2022 Update: A Scientific Statement From the American Heart Association
July 20, 2022
Assessment and management of obesity and metabolic syndrome in children with CKD stages 2-5 on dialysis and after kidney transplantation
Alport syndrome in children: moving towards early diagnosis and treatment
July 14, 2021
Urinary tract infection (UTI)
October 20, 2021

SOCIAL MEDIA GROUP

IPNAJC was developed by Social Media Group of the IPNA Communications Committee:

  • Michal Malina (@DrMalinaM)
  • Sudha Mannemuddhu (@drM_sudha)
  • Swasti Chaturvedi (@SwastiThinks)
  • Juan Kupferman (@kidnyhealth)
  • Abdul Qader (@md_abdulqader83)
  • Maury Pinsk (@maurypinsk)
  • Shweta Shah (@nefron1310)
social media@2x
IPNA App is here.
🎉

IPNA App is here.

We’re happy to announce that you can download our free app from now on.

Go to IPNA Foundation